Trust Size
$114M
Peak Price
$134.00
Current Price
$1.21
Return
-87.9%
Price Journey
What Happened
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived cell therapies for cancer, immune disorders, and degenerative diseases.
Celularity went public in July 2021 through a merger with GX Acquisition Corp II. Founded by stem cell pioneer Robert Hariri, the company uses placental stem cells to develop allogeneic cell therapies that don't require patient-specific manufacturing. The company has reported going concern warnings and the stock has declined significantly, though it continues to advance its clinical pipeline.
Timeline
2019-05-13
S-1 Registration Filed
SEC Filing Details
CIK Number
1752828
Total SEC Filings
519
State of Incorporation
DE
Last Filing Date
2026-03-10
Business Location
New York, NY
Trust/Asset Size
$114M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Celularity